Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted pipecoloxylidide. It is the S-enantiomer of bupivacaine. Levobupivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Chirocaine. Compared to bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action. It is approximately 13 per cent less potent (by molarity) than racemic bupivacaine.Levobupivacaine is indicated for local anaesthesia including infiltration, nerve block, ophthalmic, epidural and intrathecal anaesthesia in adults; and infiltration analgesia in children. Adverse drug reactions (ADRs) are rare when it is administered correctly. Most ADRs relate to administration technique (resulting in systemic exposure) or pharmacological effects of anesthesia, however allergic reactions can rarely occur.
CAS: 27262-48-2
Standard: ≥99.0%
Appearance: White or off white crystalline powder
Usage: Anesthetic
Package: 5kg/10kg
关键字： 医药中间体；盐酸盐
济南诚汇双达化工有限公司隶属于山东诚创医药集团，成立于2002年5月，公司集研发、生产、销售为一体，技术力量雄厚，检测手段先进，拥有强大的研发能力，是专业生产医药中间体、原料药和精细化工产品的高科技企业。公司致力于局部麻醉、抗癌、抗抑郁、抗老年痴呆和心脑血管领域的药物研发与生产，特别是在局部麻醉药物合成方面，处于国内领先地位；公司产品主要以出口为主，产品远销东南亚、南美、东欧等40余个海外国家和地区。公司研究中心形成了以归国专家、博士、硕士等中青年为骨干高层次人才团队，知识结构合理，本专科以上学历的科技人员共计180余人，占职工总数的40%以上，其中现有博士5人，硕士35人，中高级专职研究人员60余人；拥有3000